ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Surface fluid registration of conformal representation: Application to detect disease burden and genetic influence on hippocampus

Shi, Jie; Thompson, Paul M.; Gutman, Boris; Wang, Yalin*
NeuroImage2013-9DOI: 10.1016/j.neuroimage.2013.04.018
67被引1阅读
引用收藏
分享

摘要

In this paper, we develop a new automated surface registration system based on surface conformal parameterization by holomorphic 1-forms, inverse consistent surface fluid registration, and multivariate tensor-based morphometty (mTBM). First, we conformally map a surface onto a planar rectangle space with holomorphic 1-forms. Second, we compute surface conformal representation by combining its local conformal factor and mean curvature and linearly scale the dynamic range of the conformal representation to form the feature image of the surface. Third, we align the feature image with a chosen template image via the fluid image registration algorithm, which has been extended into the curvilinear coordinates to adjust for the distortion introduced by surface parameterization. The inverse consistent image registration algorithm is also incorporated in the system to jointly estimate the forward and inverse transformations between the study and template images. This alignment induces a corresponding deformation on the surface. We tested the system on Alzheimer's Disease Neuroimaging Initiative (ADNI) baseline dataset to study AD symptoms on hippocampus. In our system, by modeling a hippocampus as a 3D parametric surface, we nonlinearly registered each surface with a selected template surface. Then we used mTBM to analyze the morphometry difference between diagnostic groups. Experimental results show that the new system has better performance than two publicly available subcortical surface registration tools: FIRST and SPHARM. We also analyzed the genetic influence of the Apolipoprotein E(is an element of)4 allele (ApoE4), which is considered as the most prevalent risk factor for AD. Our work successfully detected statistically significant difference between ApoE4 carriers and non-carriers in both patients of mild cognitive impairment (MCI) and healthy control subjects. The results show evidence that the ApoE genotype may be associated with accelerated brain atrophy so that our work provides a new MRI analysis tool that may help presymptomatic AD research.

学科与关键词

关键词
Nonlinear image registrationSurface conformal parameterizationConformal representationSurface fluid registrationTensor-based morphometryPresymptomatic AD
相关
加载中…
  • Genetic Influence of Apolipoprotein E4 Genotype on Hippocampal Morphometry: An N=725 Surface-Based Alzheimer's Disease Neuroimaging Initiative Study
    Shi, Jie; Lepore, Natasha; Gutman, Boris A.; Thompson, Paul M.; Baxter, Leslie C.; Caselli, Richard J.; Wang, Yalin*HUMAN BRAIN MAPPING, 2014, 35(8): 3903-3918.被引 60
  • Quasi-conformal statistical shape analysis of hippocampal surfaces for Alzheimer's disease analysis
    Chan, Hei Long; Li, Hangfan; Lui, Lok Ming*NEUROCOMPUTING, 2016, 175: 177-187.被引 17
  • Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls
    Barnes, Josephine*; Lewis, Emma B.; Scahill, Rachael I.; Bartlett, Jonathan W.; Frost, Chris; Schott, Jonathan M.; Rossor, Martin N.; Fox, Nick C.Journal of Computer Assisted Tomography, 2007, 31(4): 581-587.被引 16
查看全部 →

发表信息

论文状态
公开发表
期刊
NeuroImage
发表日期
2013-09
卷期
第 78 卷
页码
111-134
DOI
10.1016/j.neuroimage.2013.04.018
语言
ENGLISH
期刊等级
Q1
成果收录
SCIE
资助标注
Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; Janssen Alzheimer Immunotherapy Research & Development LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; Takeda Pharmaceutical Company; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Dana Foundation

作者

  • S

    Shi, Jie (第一作者)

  • T

    Thompson, Paul M.

查看全部 4 位作者收起作者
  • G

    Gutman, Boris

  • W

    Wang, Yalin (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417